1. Home
  2. HURN vs HCM Comparison

HURN vs HCM Comparison

Compare HURN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

SELL

Current Price

$174.55

Market Cap

2.5B

ML Signal

SELL

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

SELL

Current Price

$14.10

Market Cap

2.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HURN
HCM
Founded
2002
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
HURN
HCM
Price
$174.55
$14.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
12
Target Price
★ $190.75
$20.59
AVG Volume (30 Days)
★ 241.6K
47.3K
Earning Date
10-27-2026
07-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.34
N/A
Revenue
★ $1,699,143,000.00
N/A
Revenue This Year
$12.58
$14.24
Revenue Next Year
$8.97
$11.52
P/E Ratio
$131.01
★ $5.49
Revenue Growth
★ 11.65
N/A
52 Week Low
$84.88
$9.77
52 Week High
$186.78
$16.33

Technical Indicators

Market Signals
Indicator
HURN
HCM
Relative Strength Index (RSI) 66.82 54.37
Support Level $119.02 $13.93
Resistance Level $186.78 $14.44
Average True Range (ATR) 5.96 0.34
MACD 1.33 -0.10
Stochastic Oscillator 72.72 50.91

Price Performance

Historical Comparison
HURN
HCM

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: